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Abstract 
Objective: To compare the effects of GnRH agonists (long 
protocol) and GnRH antagonists (short protocol) on embryo 
quality, endometrial thickness (ET) and pregnancy rate in human 
in vitro fertilization (IVF). 
Subjects & Methods: In this quasi experimental study 237 
patients underwent short protocol and 175 long protocol of IVF. 
hCG was administrated when 2 or more follicles reached the size 
of 18mm. After 34-36 hours’ oocytes were retrieved 
transvaginally. ET was carried out after 3-5 days under ultrasound 
guidance. Rising β-hCG concentration confirmed the diagnosis of 
pregnancy. 
Results: There was no significant difference in proportion of 
primary and secondary sub fertility between the two groups. 
Regarding female age, embryo quality and endometrial thickness 
no significant difference was found between two groups. Number 
of attempts, no of oocytes, fertilization & cleavage rate, 
maturation of oocytes and embryos transferred were significantly 
associated with both long and short protocols.  
Conclusion: Ongoing research in assisted reproductive 
technology has identified some issues which are important from 
the patient point of view such as ovarian hyper stimulation and 
safe successful pregnancy. This study shows that pregnancy rate is 
better with long protocol but that is not statistically significant. 
More studies should be designed with increase power for suitable 
comparison of long GnRH agonist protocols with short GnRH 
antagonist protocols.  
Keywords: Embryo quality, Endometrial thickness, GnRH 
agonist (long), GnRH antagonist (short), Oocytes, Ovarian 
stimulation, Pregnancy rate, Uterine endometrium. 
 
Introduction 
In the last 50 years, development of assisted reproduction 
and unprecedented success has given hope to couples who 
were considered sub-fertile and constituted 10-15% of the 
general population. In the developed nations 1% of the 
children are thought to be conceived with the help of 
assisted reproductive technology (ART).
1
 Since the birth of 
Louise Brown, first "test tube baby” more than five million 
babies have been born worldwide with the help of ART.
2 
Joint research and collaboration between diversified 
scientific fields like biology, physiology, endocrinology, 
embryology, laboratory science and clinical medicine 
resulted in development of ART of today.
3
 Howard and 
Jones in USA and Trounson from Australia pioneered COH 
(controlled ovarian hyperstimulation) by using 
gonadotropins derived from the urine and provided a useful 
tool for in vitro fertilization (IVF).
4-6 
These injectable 
gonadotropins made it possible to expose ovarian follicles 
to higher hormonal levels and make a larger number of 
ovarian follicles to mature into oocytes which can be 
retrieved predictably in a large number from a single IVF 
cycle.
6   
 
In order to suppress internal secretion of pituitary 
gonadotropin, GnRH agonists are used which help in 
revolutionizing the process and procedure of stimulation of 
the ovaries and prevention of LH (luteinizing hormone) 
surge. It is named as super ovulation.
7,8
 When greater 
number of good quality embryos is needed for transfer into 
the uterus, higher number of pre-ovulatory follicles is 
required to be recruited to yield better quality oocytes. This 
is done by hyper stimulation of the ovaries by external 
recombinant gonadotrophins.
9,10 
Average number of 
follicles recruited in an ovarian stimulation cycle have risen 
to ten, twenty or more, which have led to the yield of 
enhanced number of oocytes per cycle.
11 
Higher number of 
oocytes retrieved has been linked with greater chances of 
pregnancy.
12 
Manipulation of menstrual physiology with the 
help of drugs and surgery is the key to success in ART.
13
 
GnRH agonists utilize agonistic analogues of gonadotropins 
which have some amino acids substitutions in their amino 
acid sequence which happen to make them more competent 
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and enhance their half lives in comparison with the natural 
hormones. GnRH agonists provide continuous release of 
gonadotropin secretion.
14 
GnRH antagonists cause sudden 
chemical suppression of the pituitary, thereby causing 
shutdown of LH (luteinizing hormone) and FSH (follicle-
stimulating hormone) secretion.
15
 GnRH analogues are 
given to the women undergoing ovarian hyper-stimulation 
to obviate LH surge which may cause the follicles to 
ovulate prematurely. This helps the leading follicles to 
reach the optimum size. This is followed by injection of 
ovulation trigger which is hCG (human chorionic 
gonadotropin). History of the menstrual cycle provides 
information about the day of ovulation of the natural cycle 
which helps the clinician to schedule the visits of the patient 
for hormone tests and ultrasound examination. Experienced 
clinician, after evaluating the situation of the patient, 
chooses the drugs, doses and time of ovulation induction 
from the available protocols.
16
 
So called long protocol consist of giving external 
recombinant gonadotropin along with GnRH agonists and 
causing suppression of pituitary FSH and LH.  By this 
protocol cancellation rate is reduced and there is increase in 
recruitment of the follicles and getting larger number of 
oocytes. The incidence of premature surges of LH is also 
remarkably reduced.  Ovarian stimulation, through the use 
of GnRH agonists, helps to improve pregnancy rate as a 
result of IVF.
10
 In the short protocol GnRH antagonists are 
used in ART. They are highly potent and are effective in 
lower dosage.
17 
Suppression of anterior pituitary is more 
rapid in the short protocol thereby preventing LH release. 
The suppression is also easily and rapidly reversible. Their 
mode of action is pharmacologically different from GnRH 
agonists.
14 
GnRH antagonists are given in the mid-cycle 
which prevents an early LH surge.
18 
No suppression occurs 
in the beginning of follicular phase which is an important 
time for recruitment of the follicles. Ovarian stimulation by 
GnRH antagonist protocol is not only short but also cost 
effective.
17
 Perfect synchronization of female endocrines, 
endometrial physiology and embryonic factors form the 
basis of molecular communication between the uterine 
endometrium and upcoming embryo which helps in 
implantation and subsequent conception.
19 
Changes in 
morphology of the endometrium and hormonal secretion 
ensure proper embryo transfer and implantation capable of 
progression to pregnancy.
20 
Operational Definitions 
Embryo quality: Embryo quality (EQ) is based on 
division, age of embryo, day of embryo and degree of 
fragmentation or nucleation. And it is graded as grade 1, 2 
or 3. 
Endometrial thickness: Thickness of lining of uterus, more 
than 8mm is considered for ET. 
Pregnancy Rate:Pregnancy Rate is the success rate for 
getting pregnant. It is the percentage of all attempts that 
leads to pregnancy. 
Chemical pregnancy:β-hCG level <10 IU/L for the first 
time. 
Clinical pregnancy:β-hCG level testing >10 IU/L with 
pregnancy on ultrasound examination. 
Long protocol: Ovarian stimulation protocol using GnRH 
analogue in mid-leuteal phase of previous cycle is called 
long protocol (21
st 
day of cycle down regulation). 
Antagonist protocol:Ovarian stimulation protocols using 
GnRh antagonist is called antagonist protocol. 
 
Subjects and Methods 
In this quasi experimental study total number of 412 cases 
undergoing IVF were included who attended LIFE ART 
clinic at a private hospital in Lahore from 1
st
 January to 30
th
 
June 2015.This study was approved by LIFE and HLH 
Ethical Committee. After taking approval from the 
institutional review board a specially designed 
questionnaire was used for data collection. The 
questionnaire was validated by LIFE research cell 
biostatistician.  Patients who were not suitable for ET were 
excluded from data. Before signing the consent form, the 
couples were informed about the procedure and processes 
in detail. Anonymization and de-identification of the 
couples was carried out prior to the analysis of the data. 
Down-regulation was carried out in patients in the long 
protocol (n=175) group by starting the injection 
Decapepyle1.0 mg-1.3 mg from day 21 of the menstrual 
cycle. Serum level of E2 <30 pg/ml and LH <2 mIU/ml 
confirmed full suppression of pituitary gland. Recombinant 
FSH (Gonal-F, Puregon, Follitropin) were also given on 
regular daily basis. Ovarian response helped in adjusting the 
dosage of external FSH and LH. 
When 2 or more follicles reached the size of 18 mm 
recombinant hCG (Pregnyl) was given. 34-36 hours after 
hCG administration oocytes were retrieved transvaginally. 
The patients on short protocol (n=237) GnRH antagonist 
(Cetrotide, Orgalutran) were started on 2nd day of the 
menstrual cycle and were continued till hCG administration. 
Embryo transfer took place after three to five days under 
ultrasound guidance. Fourteen days after embryo transfer, 
rising concentration of β-hCG confirmed pregnancy. 
Data was entered on SPSS version 15.0 and analyzed.  For 
continuous variables mean, SD and SE were calculated. For 
categorical variables frequencies and percentages were 
calculated. Chi-square test was used to check association 
for categorical variables and t-was used of continuous 
variables. Multiple logistic regression was used to 
determine the relationship between pregnancy and factors 
that influence the outcome. 
Results 
There was no significant difference in proportion of primary 
and secondary subfertility between two groups. There was 
also no significant difference between two groups in female 
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age, embryo quality, FSH (on day three) Number of 
attempt, no of oocytes, fertilization, cleavage rate, 
maturation of oocytes and embryos transfer were 
significantly associated with both long and short protocol 
(table 1). In long acting GnRH group 1, fertilization rate 
was 62.74% and cleavage rate was 94.46% while in short 
acting GnRH group 2, fertilization rate was 61.89% and 
cleavage rate was 92.61%. In agonist (long protocol)  had 
positive pregnancy test and (72%) had negative pregnancy 
test while in antagonist (short protocol) (24.1%) had 
positive pregnancy test and (75.9%)  had negative 
pregnancy test. (Table 2) 
Rate of good quality embryos in long acting GnRH group 
was 28% and in short acting GnRH group was 24%. 
Primary subfertility had 26.4 % while secondary subfertility 
had 17.6% rate of good embryo quality (Table 3). Female 
age and endometrial thickness were significantly associated 
with pregnancy outcome. Pregnancy rate was improved as 
the endometrial thickness (p-value=0.05) increased. The 
estimated odds ratio (OR) of positive pregnancy with 
female age was (1.075), type of infertility (1.454), 
endometrial thickness (0.868), no of embryo transfer 
(0.986) and protocol (1.066) respectively. (Table 4) 
 
Table 1:  General characteristics of patients treated with the 
short and long protocol (GnRH) for ovarian stimulation 
Variables 
Long-
acting(n=175) Short-acting(n=237) p-values 
    Female age (years) 
(mean±SD) 30.±4. 31.±5.1 0.071 
    Proportion of 
primary  
subfertility n(%) 161(92) 217(92) 
 
0.873 
Proportion of  
secondary 
subfertility, n(%) 14(8) 20(8) 
 No of attempt 
(mean±SD) 1.1±0.5 1.2±0.529 0.034 
No of oocytes 
(mean±SD) 11.±5.3 10.±5.232 0.004 
Fertilization rate, 
n(%) 
1120/1785 
(62.74) 1259/2034 (61.89) 0.009 
Cleavage rate, n(%) 1058/1120(94.46) 1166/1259 (92.61) 0.009 
Matured (mean±SD) 10.2000±4.8848 8.5641±6.0084 0.017 
Embryo transferred 
(mean±SD) 1.8092±0.7855 1.5511±0.6212 0.0001 
On day 3 
   FSH [mlU/ml], 
(mean±SD) 7.5534±6.9503 7.1815±2.9639 0.106) 
On the day of 
HCG 
administration 
   P4 [ng/ml], 
(mean±SD) 5.2232±2.1554 6.4222±3.9793 NS(0.414) 
Endometrial 
thickness [mm], 
(mean±SD) 9.8573±1.6921 9.5574±1.6033 NS(0.635) 
Table 2:Association of long vs short protocol with respect to 
pregnancy test 
                       Protocol p-value 
Pregnancy Agonist(long) 
(n=175) 
Antagonist(short) 
(n=237) 
 
 
 
0.356 
Positive  
n(%) 
49 (28.0) 57(24.1) 
Negative  
n(%) 
126(72) 180 (75.9) 
 
Table 3: Association of IVF outcome predictors and embryo quality 
 embryo quality 
Variables 
Good 
Embryo 
quality(n) 
Average 
Embryo 
quality(n) 
Rate of good 
Embryoquality 
(%)% 
Protocol 
   
Long,GnRH(a) 49 126 28 
Short, GnRH(anta) 57 180 24 
Type of 
subfertility 
   
Primary 100 278 26.4 
Secondary 6 28 17.6  
 
Table 4: Association between pregnancy and factors that 
influence the outcome. 
 
Variable B SE Wald d.f OR 95% CI p-value 
female age 0.073 0.024 9.175 1 1.075 1.026 - 1.127 0.002 
subfertility(primary, 
secondary) -0.374 0.476 0.618 1 1.454 0.572 - 3.697 0.432 
endometrial thickness -0.142 0.075 3.55 1 0.868 0.748 - 1.006 0.05 
number of embryo 
transfer -0.014 0.162 0.007 1 0.986 0.718 - 1.356 0.986 
protocol (long, short) 0.063 0.238 0.071 1 1.066 0.669 - 1.698 0.79 
 
Discussion 
In our research primary and secondary subfertility, embryo 
quality, FSH (on day three), serum E2 and progesterone 
(P4) level on day of hCG injection and endometrial 
thickness had insignificant association with long and short 
protocol. Female age, number of attempt, no of oocytes, 
fertilization, cleavage rate, maturation of oocytes and 
embryos transfer were significantly associated with long 
and short protocol. Fertilization rate and cleavage rate was 
63.79 % and 94.28% for long protocol; 64.53% and 
92.47% for short protocol. Percentage of good quality 
embryos in the long protocol was 28% and short protocol 
was 24%. The pregnancy rate with long protocol was 28.0% 
whereas 24.1 % with short protocol. Age of the female and 
endometrial thickness showed a significant association with 
the pregnancy outcome in the logistic regression model. 
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Primary and secondary subfertility had insignificant 
association with long and short protocol of ovarian 
stimulation in IVF/ ICSI. 
Main aim of assisted conception is to improve pregnancy 
rate in couples with subfertility. In vitro fertilization and 
embryo transfer in the subfertile females leading to clinical 
pregnancy became possible because of intelligent 
assessment of needs of individual patient and a personalized 
tailoring of COH and successful recruitment of adequate 
number of oocytes.
21
 
In many cases the response of the females to COH is not 
adequate and failure of treatment is imminent. These 
females are called poor responders who need an 
individualized ovarian stimulation protocol.
22
 Pregnancy 
rate after undergoing IVF got better because of using GnRH 
agonists for COH. Untimely early LH surges were also 
lessened due to GnRH agonists.
11
 GnRH antagonists have 
lesser side effects and also prevent early LH surges.
14
 When 
GnRH antagonist suppresses the pituitary secretion of 
gonadotropins, it can be reversed rapidly.
23 
Short GnRH 
antagonist protocol is flexible, effective and easier to use 
and may become an alternative to the long protocol.
14 
Greenblatt, Meriano and Casper looked into type of COH 
protocols (both long and short) in 34 consecutive ICSI 
cycles and their effect on oocyte maturity, rate of 
fertilization and cleavage. All these three parameters 
appeared to be better with the long protocol. More oocytes 
became mature (metaphase II) as well as more cleaving 
embryos were seen with long GnRH protocol with a higher 
fertilization rate in comparison with short GnRH antagonist 
protocol.
24 
Successful IVF depends on maturation of 
adequate number of oocytes. Chances of Successful 
fertilization and subsequent clinical pregnancy are 
decreased when the retrieved oocytes are meiotically 
incompetent.
25
 Al-Inany and Aboulghar published a 
systematic review in 2002 in which long and short protocols 
were compared for efficacy in assisted reproduction by 
COH. Short protocol was shown to have resulted in lesser 
number of clinical pregnancies (OR 0.79; 95% CI 0.63-
0.99). As far as premature LH surges’ prevention is 
concerned OR was found to be 1.76 [95% confidence 
interval (CI) 0.75-4.16].
24
 
Malmusi et al., found that pregnancy rate was better with 
long protocol whereas implantation was similar in long and 
short protocol. Retrieval of higher number of matured 
oocytes and greater number of good quality embryos were 
also shown in long protocol.
26
 A prospective study was 
done on the data from 4 Egyptian universities' "integrated 
fertility centers” by Youssef et al. in 2008. Women over the 
age of 40 were included who had a normal hormonal profile 
and no pelvic abnormality. Women who received long 
protocol were 285 whereas 246 women received short 
protocol. Standard ICSI procedure was performed. 
Pregnancy rate achieved by long protocol was 26.6 % and 
by short protocol was 10.2% (P <0.001).
27
 Mao et al. 
published retrospective analysis of comparison between 
long and short protocol in 2014, regarding thickness of the 
endometrium, quality of embryo and pregnancy rate. No 
significant differences were noted between long and short 
protocols for embryo quality, (63.16% vs. 66.26%, p> 
0.05). Pregnancy rate was higher with long protocol as 
compared to short protocol (59.60% vs. 43.42%, p < 0.05) 
Type of subfertility and endometrial thickness had 
significant association with pregnancy success as shown by 
logistic regression analysis.
28
 Cheung et al. in 2005 
published a randomized controlled trial comparing GnRH 
antagonist and long GnRH agonist protocol in women who 
underwent assisted reproduction (IVF) but were identified 
as poor responders. They were not able to find any 
significant differences in many important parameters like 
cancellation rates, stimulation duration, gonadotropins 
consumed, and average numbers mature follicles, oocytes, 
and number of embryos acquired. The antagonist group had 
higher number of embryos transferred, means and standard 
deviations being 2.32, 0.58 versus 1.50, 0.83 (P = 0.01). 
Implantation rates were similar but pregnancy rates were 
higher for the antagonist group, though the difference was 
insignificant statistically.
29 
Ovarian response is categorized 
on the basis of levels of serum FSH and E2, number of 
oocytes, dose of gonadotropin and cycle cancellation rate. 
Females with lower number of oocytes (>4) were labeled as 
poor responders and FSH higher than 300 IU was taken as 
no ovarian response. 
15
 
 
Conclusion 
In this study, pregnancy rate is better with long protocol but 
that was not statistically significant. More studies should be 
designed to compare long GnRH agonist protocols with 
short GnRH antagonist protocols with increase sample size 
for suitable comparison.  
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